It is a pharma public limited company based in Hyderabad, Telangana, India, established in 2010.
2010 | Hyderabad, Telangana, India | ActiveSumeru Pharma Limited, a active public limited company, was established on 26 November 2010 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2010PLC071400. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹1.05 Cr.
It upholds a active non-compliant status. Its leadership includes Devineni Rahul Chowdary (Director), Kuchipudi Ramajogeswara Rao (Director), Devineni Padmaja (Managing Director). Past directors included Devineni Rahul Chowdary, Devineni Padmaja, Devineni Venkateswara Rao. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at Plot No 80, Vivekananda Nagar Kukatpally, Hyderabad, Telangana, 500072.
U24232TG2010PLC071400
071400
26 November 2010
₹4.50 Cr
₹1.05 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sumeru Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devineni Rahul Chowdary | Director | 15 Apr 2011 | Current |
| Kuchipudi Ramajogeswara Rao | Director | 26 Nov 2010 | Current |
| Devineni Padmaja | Managing Director | 26 Nov 2010 | Current |
| Devineni Sai Sahul | Director | 26 Nov 2010 | Current |
| Devineni Venkateswara Rao | Director | 26 Nov 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Jul 2011 | Past |
| Pramod Abcsdd | Director | 23 Mar 2015 | Past |
| Pramod Abcsdd | Managing Director | 31 May 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sumeru Pharma Limited, for the financial year ended 2015, experienced Minor drop in revenue, with a 3.6% decrease. The company also saw a substantial improvement in profitability, with a 111.88% increase in profit. The company's net worth moved up by a moderate rise of 0.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2015, Sumeru Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2012 | Canara Bank | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sumeru Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sumeru Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sumeru Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sumeru Pharma Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was completed.
The activity Sumeru Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Hyderabad. was completed.
The activity A charge with Canara Bank amounted to Rs. 1.00 Cr with Charge ID 10349446 was registered on 30 Mar 2012. was completed.
Progress on Devineni Rahul Chowdary was appointed as a Director was appointed as a Director on 15 Apr 2011 & has been associated with this company since 14 years 7 months . was documented.
Kuchipudi Ramajogeswara Rao was appointed as a Director was appointed as a Director on 26 Nov 2010 & has been associated with this company since 15 years 7 days . was recorded as a recent event.
Devineni Padmaja was appointed as a Managing Director was appointed as a Managing Director on 26 Nov 2010 & has been associated with this company since 15 years 7 days . was recorded as a recent event.
The CIN of Sumeru Pharma Limited is U24232TG2010PLC071400.
Sumeru Pharma Limited is headquartered at Plot No 80, Vivekananda Nagar Kukatpally, Hyderabad, Telangana, 500072.
Sumeru Pharma Limited was incorporated on 26 November 2010.
The current directors of Sumeru Pharma Limited are
The primary industry of Sumeru Pharma Limited is Manufacturing.
Sumeru Pharma Limited is unlisted.
The authorized capital of Sumeru Pharma Limited is ₹4.50 Cr, and the paid-up capital is ₹1.05 Cr.
The compliance status of Sumeru Pharma Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX